Hematology. Hematology testing will be performed on Day 1 and at Months 6, 12, 18, and 24. The following tests will be performed: Hematology: · Hemoglobin · Hematocrit · WBC count with differential in absolute counts · RBC count · Mean corpuscular volume (MCV) · Mean corpuscular hemoglobin concentration (MCHC) · Mean corpuscular hemoglobin (MCH) · Platelet count
Hematology. Targets principally involved in [**], including, without limitation, [**], but excluding Targets of [**]. Inflammatory Disease: Targets principally involved in [**]. Such disorders include, without limitation, those [**], including [**], but excluding Targets of [**].
Hematology. Hematology studies will be evaluated at screening (Visit 1), Visit 10 (week 28) and end of treatment (Visit 17 at week 56 or study withdrawal) for hemoglobin, hematocrit, red blood cell count (RBC), total white blood cell count (WBC), WBC differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils) and platelet count.
Hematology. Samples will be collected for the following hematology assessments as indicated in Table 3: hematocrit, hemoglobin, red blood cell (RBC) count, white blood cell (WBC) count, neutrophils, bands (if detected), lymphocytes, monocytes, basophils (if detected), eosinophils (if detected), absolute platelet count, mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), and mean corpuscular hemoglobin concentration (MCHC).
Hematology. Hematology tests will include complete blood count, including red blood cells, white blood cells with differentiation, hemoglobin, hematocrit, reticulocytes, and platelets. The coagulation panel will include activated partial thromboplastin time, prothrombin time, and international normalized ratio.
Hematology. The following hematology tests will be performed: • hemoglobin • hematocrit • platelet count • absolute neutrophil count (ANC) • white blood cell (WBC) count and differential count — polymorphonuclear leukocytes (neutrophils) — lymphocytes — eosinophils — monocytes — basophils — metamyelocytes
Hematology. Blood will be obtained and sent to each site’s clinical hematology lab for a complete blood count (hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count).
Hematology. Blood will be obtained as noted in the Schedule of Events and sent to each site’s clinical hematology lab for a complete blood count (hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count). If values are abnormal and clinically significant at Visit 4, a sample will be collected and these parameters re-evaluated at a follow-up visit two weeks later.
Hematology. Diseases of the bone marrow or of cells originating in [**] and excluding hematologic diseases of [**]. Hepatic: Diseases of the [**], including, [**] and excluding hepatic diseases of [**]. Inflammatory Disease: [**], including those [**], including [**] and excluding inflammatory diseases of [**]. Musculoskeletal Disease: Diseases of the muscles, ligaments or bone, including, [**] and excluding musculoskeletal diseases of [**]. Neurodegenerative Disease: [**] involving [**], including [**] and excluding neurodegenerative diseases of [**].
Hematology. Blood will be obtained as noted in the Schedule of Events and sent to each site’s clinical hematology lab for a complete blood count with differential (i.e., hemoglobin, hematocrit, red blood cell count, white blood cell count, white blood cell differential, and platelet count).
